Trial Profile
The clinical trial of Apatinib combined with chemotherapy treat for the second-line advanced cancer of the stomach or gastroesophageal junction adenocarcinoma
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2020
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Rivoceranib (Primary) ; Antineoplastics
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress
- 08 Nov 2016 New trial record